Men with prostate cancer who take the cholesterol-lowering drugs known as statins are significantly less likely to die from their cancer than men who do not take such medication, according to a new study.
For patients with early cancer, a nurse navigator intervention can improve patient experience and reduce problems with care, according to a study published online Nov. 25 in the Journal of Clinical Oncology.
Use of a minimally invasive endoscopic procedure to remove superficial, early-stage esophageal cancer is as effective as surgery that removes and rebuilds the esophagus, according to a new study.
Breast cancer is treated differently in men than in women, with regard to frequency of both mastectomy and radiation treatment.
Performing early stem cell transplants in patients with aggressive non-Hodgkin lymphoma does not improve overall survival in high-risk patients, according to a new study. However, early transplantation appears to be beneficial among the small group of patients who are at the very highest risk.
Black patients with metastatic colorectal cancer are less likely to be seen by cancer specialists or receive cancer treatments. The study did not ascribe a specific cause for the racial disparities but offered six possible explanations.
More than 500,000 women in the United States have a breast biopsy each year. Percutaneous biopsies are associated with fewer complications than the surgical approach, but short-term side effects such as pain and emotional distress are still significant.
In patients with resectable hypopharyngeal and laryngeal cancers, a trend toward worse HRQOL scores was found in patients receiving alternating chemoradiotherapy compared to patients receiving sequential induction chemotherapy and radiotherapy.
Results from a new study could benefit some children with high-risk AML. A therapeutic regimen that combined the GO with conventional three-drug chemotherapy was associated with improved survival in children with AML who underwent bone marrow transplantation.
Cancer survival tends to be far lower when patients have comorbid diseases, based on a systematic review of 10 years of data from Denmark and elsewhere. The effects of comorbidities on survival varied by cancer type, but overall trends were comparable, researchers said.
Adult patients with Burkitt lymphoma had excellent long-term survival rates—upwards of 90%—following treatment with low-intensity chemotherapy regimens, according to a new clinical trial finding.
A new study has found that several months after surgery for esophageal cancer, different symptoms cluster together in different types of patients. In addition, patients with certain symptom clusters have an increased risk of dying from their disease.
Mutations in the genes that defend the body against cancer-related viruses and other infections may play a larger role in breast cancer than previously thought.
As with any treatment regimen that results in physical impairment, patients with cancer need rehabilitation therapy to return to baseline functioning.
For patients who fail to respond to current first-line and second-line treatments for colorectal cancer liver metastases (also known as salvage patients), radioembolization with Y-90 microspheres could extend survival.
Advanced imaging techniques may be able to distinguish which patients' tumors will respond to treatment with antiangiogenic drugs and which will not.
Although a breast cancer diagnosis is usually an extremely stressful experience for most women, a new study has found that there also can be unexpected benefits.
Men with prostate cancer who are overweight or obese at diagnosis are more likely to die from the disease than men who are of healthy weight, according to a newly published study.
Patient assistance programs can help breast cancer patients meet a variety of needs. When these needs are unmet, they can interfere with getting recommended adjuvant therapies such as radiation, chemotherapy, and hormonal treatments.
Can the drug paroxetine mesylate (Brisdelle, Paxil) be given to patients taking a chemoprevention drug such as raloxifene (Evista) or any of the aromatase inhibitors?
A functional biomarker that can predict whether BRAF-mutant melanomas respond to drugs targeting BRAF could help guide the treatment of patients with these cancers.
A team of researchers has identified a novel mutation in the hepatitis B virus (HBV) in Korea that appears only in men and could help explain why HBV-infected men are roughly five times more likely than HBV-infected women to develop liver cancer.
Cancer-specific physical therapy can provide closure to cancer treatment and offers patients a link to their pretreatment physical baseline.
An inherited gene variation has been linked to a nearly fourfold increased risk of developing a pediatric acute lymphoblastic leukemia subtype that is associated with a poor outcome.
An optical imaging technique that measures metabolic activity in cancer cells can accurately differentiate breast cancer subtypes, and can detect responses to treatment as early as 2 days after therapy administration.
Consistent users of the Internet were more likely than never-users to engage in cancer-preventive behaviors, a large study revealed.
Patients with bladder cancer are two times more likely to have complications after a radical cystectomy procedure if they have a biomarker for poor nutritional status before the operation, according to a study.
Despite long-running evidence demonstrating that a single session of radiotherapy provides just as much pain relief to patients with terminal cancer as multiple treatments, the method has yet to be adopted into routine practice.
Findings from a study involving thousands of postmenopausal women suggest that women who develop invasive breast cancer may benefit from taking supplements that contain both multivitamins and minerals.
Both treatment and survival are improved when a tumor whose primary site is unknown has its molecular profile identified.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|